Summit Therapeutics Inc Sustainability Reports
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel oncology therapies. Its lead product candidate is ivonescimab, a potential first-in-class bispecific antibody designed for the treatment of solid tumors.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00X3GQL94
5 reports from 2015 to 2024